Vol picking up for LOXO as well. Draft Order on Drug Prices Proposes Easing Regulations - https://www.nytimes.com/2017/06/20/...-drug-prices-proposes-easing-regulations.html FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes - https://finance.yahoo.com/m/e959ac41-9811-34e0-8017-60bae0daaf9f/fda-moves-to-clear-path-for.html
News out - trading should start soon >> Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress - https://www.gurufocus.com/news/5637...uropean-society-for-medical-oncology-congress
Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma - https://finance.yahoo.com/news/array-biopharma-announces-fda-acceptance-130900028.html
Is right up against 50 ma - FDA results 11/10 - "... posted revenue of $29.7 million, surpassing Street forecasts. Five analysts surveyed by Zacks expected $22.3 million. Array BioPharma shares have risen 21 percent since the beginning of the year. The stock has climbed 83 percent in the last 12 months..." https://finance.yahoo.com/news/array-biopharma-reports-1q-loss-120831392.html
